Salvage stereotactic body radiation therapy re‐irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report-Reference-Cited by-同舟云学术

Salvage stereotactic body radiation therapy re‐irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report

Published:2023-07-17 Issue:10 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Buchberger David S.¹,Cook Samantha K.¹,Anderson Peter M.²³,Shepard Dale R.³,Ku Jamie A.⁴,Fritz Michael A.⁴,Sindwani Raj⁴⁵⁶,Recinos Pablo⁵⁶,Murphy Erin S.¹,Koyfman Shlomo A.¹

Affiliation:

1. Department of Radiation Oncology Taussig Cancer Institute Cleveland Clinic Cleveland Ohio USA

2. Pediatric Hematology/Oncology and Bone Marrow Transplant Cleveland Clinic Children's Hospital Cleveland Ohio USA

3. Department of Hematology and Medical Oncology Taussig Cancer Institute Cleveland Clinic Cleveland Ohio USA

4. Head and Neck Institute Cleveland Clinic Cleveland Ohio USA

5. Department of Neurological Surgery Neurological Institute Cleveland Clinic Cleveland Ohio USA

6. Rose Ella Burkhardt Brain Tumor and Neuro‐Oncology Center Neurological Institute Cleveland Clinic Cleveland Ohio USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30548

Reference15 articles.

1. Increased local failure for patients with intermediate‐risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group

2. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

3. Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: Feasibility and efficacy in refractory pediatric sarcoma

4. Continuously improving ifosfamide/mesna: A winning combination

5. Excellent Tolerability of Ifosfamide and Mesna Via Continuous Infusion in a Pediatric Patient Population